• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    The Journey Venture Studio Appoints First Four Board Members

    7/24/23 9:00:00 AM ET
    $CNC
    $MGLN
    Medical Specialities
    Health Care
    Hospital/Nursing Management
    Health Care
    Get the next $CNC alert in real time by email

    Notable Seasoned Entrepreneurs Will Support Inaugural Founders-In-Residence Cohort and the Development of Future Disruptive Healthcare Startups in Phoenix

    PHOENIX, July 24, 2023 /PRNewswire-PRWeb/ -- The Journey Venture Studio announced today the appointment of the first four members to its board of directors. Each board member was sought out as a mission-aligned partner as the studio prepares to launch its first Founder in Residence Cohort.

    The first four board members include:

    Heidi Jannenga, WebPT Co-founder & Chief Clinical Officer

    Jason Wood, Managing Director with Morgan Stanley Investment Management's Next Level Fund

    Andy Lombard, CEO of Arizona Venture Development Corporation (AVC)

    Justin Bayless, Former CEO of Bayless Integrated Healthcare, Founder & CEO of Ten Figures, and Founder & President of The Journey Venture Studio

    All board members have extensive knowledge of entrepreneurship, venture capital, and healthcare. The board will be responsible for supporting the leadership of The Journey in developing new venture concepts, identifying trends and opportunities in healthcare, recruiting aspiring entrepreneurs for the Founder in Residence Program and ultimately determine which concepts will be formally spun out of the studio and incorporated as new ventures.

    "With the support of these experienced board members we are able to hit the ground running and quickly grow the scale and impact of The Journey Venture Studio," said Mark Moeremans, Managing Director of The Journey. "Each of these members are passionate about our mission to close the racial and gender opportunity gap in venture and have experience in radically transforming the tech, investment, and healthcare industries and we are honored to have them be a part of The Journey Venture Studio."

    "We are excited to partner with Justin, Mark, and The Journey Venture Studio team to further support Phoenix-based, early-stage healthcare companies led by underrepresented founders," said Jason Wood.

    The board of directors will work closely with the founders as mentors and speakers and will be considered brand ambassadors, attending exclusive VIP events and participating in speaking opportunities on podcasts, panels, and conferences. Board members are also critical in ensuring the financial health of the 501c3 non-profit, with a commitment to lead efforts around funding for the studio as well as identifying investment partners for future spin-outs.

    In addition to its Board of Directors, The Journey has begun organizing a formalized syndicate of institutional investors committed to investing in the companies that spin out of the venture studio. Early members of the investor syndicate include Morgan Stanley's Next Level Fund, the Arizona Venture Development Corporation, and Ten Figures who have pledged early stage investment into thesis-aligned portfolio companies.

    Jannenga has an extensive background in entrepreneurship and the healthcare industry. Along with co-founding WebPT, she is the Founder of the Rizing Tide Foundation, a nonprofit that is broadening the reach, impact, and accessibility of physical therapy by advancing diversity and inclusiveness in the physical therapy workforce. Jannenga is a physical therapist turned entrepreneur and business executive having served in clinical practice for 15 years as the multi-clinic site director for the Tempe, Ariz.-based company Physiotherapy Associates. She is an active member of the sports and private sections of the American Physical Therapy Association (APTA) and an engaged Arizona entrepreneurial community member, LP and mentor with Golden Seeds, PHX Ventures, Prospeq and others. . Jannenga also serves on the boards for the Arizona Community Foundation, Greater Phoenix Economic Council, Flinn Foundation, Arizona School for the Arts, SciTech Institute and the Arizona Science Center.

    Wood is the Managing Director for the Morgan Stanley Next Level Fund, focused on early-stage investments in women-led and multicultural enterprises. He has more than 20 years of direct investment and advisory experience across asset classes and sectors. Prior to joining the Morgan Stanley team, Wood served as a Managing Director with AIG, where he was responsible for the global Direct Equity and Venture Capital co-investment program. He previously served as a Vice President at Parish Capital Advisors, investing in and co-investing with diverse and emerging managers, and began his career in investment banking as an analyst at UBS and as an associate with Merrill Lynch & Co. Wood holds a B.B.A. in finance from the University of Michigan and an MBA from the New York University Stern School of Business.

    Lombard is the CEO of Arizona Venture Development Corporation (AVC), a venture capital firm, where he continues a decade-plus-long passion for energizing tech startups and entrepreneurial communities across the state. Before becoming a VC, Lombard was a prolific tech founder, building and exiting four VC-backed startups in B2B SaaS, medical device, cyber security, and wireless broadband. Lombard's many awards and highlights include being named an E&Y Entrepreneur of the Year finalist and being selected as a U.S. Presidential Tech CEO Forum member. He was co-founder of the Arizona Innovation Challenge, one of the largest business plan competitions in the U.S., as well as the founder of Venture Ready Accelerator, a world-class tech accelerator at ACA. Lombard serves on several boards, including; AZ-VC, Investment Committee; Pangaea Ventures, LP Advisory Committee (LPAC); Board Member, Schola, Inc.; Member, Technology Advisor Board - Tech Launch Arizona, the tech transfer arm of the University of Arizona.

    Bayless led Bayless Integrated Healthcare to be featured on the prestigious Inc. 5000 list for the fastest growing private companies in America three years in a row (2018, 2019, and 2020) before executing a strategic transaction with Magellan Health Inc. (NASDAQ:MGLN), a Fortune 500 company, in December 2020. Magellan Health was subsequently acquired by Centene Corporation (NYSE:CNC), a Fortune 25 company, in January 2022. Justin subsequently transitioned away from the 40 year old family business in February 2022. Justin exited the family business with a nine figure valuation and growth of employees from 6 to 600 and patients served from 200 to over 50,000 annually. Bayless recently launched Ten Figures, a culturally competent, management consulting and advisory firm supporting the development and growth in BIPOC and/or women healthcare entrepreneurs. He has previously served on several boards including Delta Dental Arizona, Dignity Health Arizona, and was previously appointed by the Governor of Arizona to both the Board of Behavioral Health Examiners as well as the Commission for African American Affairs. Bayless also serves as an advisory board member and partner to the Morgan Stanley Next Level Fund as well as a Board Trustee to his alma mater Morehouse College.

    The Journey Venture Studio is a mission-driven venture studio building disruptive healthcare companies in partnership with the next generation of diverse founders. Its mission is to close the racial and gender opportunity gap by empowering diverse founders to pursue entrepreneurship while providing resources and support to increase their odds of success. For more information visit https://thejourneyventures.com.

    The Journey Venture Studio

    The Journey, a Phoenix-based 501c3 not-for-profit entity, is a venture studio creating and launching healthcare companies to be led by underrepresented founders. With a mission to launch healthcare companies aimed at improving health outcomes while creating opportunities for historically underrepresented entrepreneurs from around the country through a tailored venture fellowship, The Journey will activate a new generation of diverse founders; leveling the playing field and bringing world-changing healthcare solutions and technology to life.

    Media Contact

    Audrey Minor, Serendipit Consulting, 602.726.4080, aminor@serendipitconsulting.com

     

    SOURCE The Journey Venture Studio

    Get the next $CNC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CNC
    $MGLN

    CompanyDatePrice TargetRatingAnalyst
    Centene Corporation
    $CNC
    10/14/2025$33.00Sell
    Goldman
    Centene Corporation
    $CNC
    7/28/2025$38.00Overweight → Neutral
    Cantor Fitzgerald
    Centene Corporation
    $CNC
    7/23/2025$30.00Overweight → Equal Weight
    Wells Fargo
    Centene Corporation
    $CNC
    7/21/2025$33.00Buy → Hold
    TD Cowen
    Centene Corporation
    $CNC
    7/16/2025$30.00Neutral → Underperform
    BofA Securities
    Centene Corporation
    $CNC
    7/10/2025$33.00Overweight → Equal-Weight
    Morgan Stanley
    Centene Corporation
    $CNC
    7/2/2025$45.00Buy → Neutral
    UBS
    Centene Corporation
    $CNC
    7/2/2025$48.00Overweight → Neutral
    Analyst
    More analyst ratings

    $CNC
    $MGLN
    SEC Filings

    View All

    Centene Corporation filed SEC Form 8-K: Regulation FD Disclosure

    8-K - CENTENE CORP (0001071739) (Filer)

    11/10/25 4:40:53 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Centene Corporation

    SCHEDULE 13G/A - CENTENE CORP (0001071739) (Subject)

    11/5/25 11:30:18 AM ET
    $CNC
    Medical Specialities
    Health Care

    SEC Form 10-Q filed by Centene Corporation

    10-Q - CENTENE CORP (0001071739) (Filer)

    10/28/25 7:59:02 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    $MGLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Burdick Kenneth A sold $2,575,601 worth of shares (66,007 units at $39.02), decreasing direct ownership by 20% to 272,365 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    12/5/25 5:06:40 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Samuels Theodore R. Ii was granted 710 shares, increasing direct ownership by 4% to 19,205 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    10/1/25 5:47:05 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Tanji Kenneth was granted 803 shares, increasing direct ownership by 16% to 5,948 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    10/1/25 5:47:11 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    $MGLN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Health Net Providing Special Assistance to Members and Providers Affected by The Pack Fire in California

    SACRAMENTO, Calif., Dec. 11, 2025 /PRNewswire/ -- Following Gov. Newsom's declaration of a State of Emergency in Mono County, Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE:CNC), is taking immediate action to support those affected by the Pack Fire. The company's priority is ensuring both its members and healthcare providers have the resources they need during this critical time. Member Prescription Information During a declared State of Emergency, impacted members have two options to secure an emerg

    12/11/25 3:00:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    Meridian Health Plan of Illinois Commits $1.15 Million to Expand St. Louis Area Foodbank Mobile Pantry Program

    "Food On The Move" aligns with Meridian's Eat Well, Be Well initiative to increase access to healthy food and nutrition awareness to underserved populations, food deserts, and rural areas in Illinois. CHICAGO, Dec. 2, 2025 /PRNewswire/ -- Meridian Health Plan of Illinois, Inc. (Meridian), a company of Centene Corporation (NYSE: CNC), announced it will provide a $1.15 million grant over the next three years to Food On The Move, a mobile food pantry program by the St. Louis Area Foodbank that brings healthy food to underserved populations and food deserts in urban communities and rural areas in Illinois. This partnership will deliver healthy food and essential resources to underserved communit

    12/2/25 9:39:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    Recent SNAP Disruptions Highlight Urgent Need for Sustained Action Against Food Insecurity

    Statewide Effort Aims to Deliver Immediate Relief and Long-Term Solutions for Families in Need SACRAMENTO, Calif., Nov. 26, 2025 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans and a company of Centene Corporation (NYSE:CNC), today announced multiple investments in 2025 aimed at tackling rising food insecurity across the state. This initiative comes at a critical time as disruptions to CalFresh and other federal nutrition programs put increased strain on millions of California families struggling to access healthy meals. The

    11/26/25 11:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    $MGLN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on Centene with a new price target

    Goldman initiated coverage of Centene with a rating of Sell and set a new price target of $33.00

    10/14/25 8:47:32 AM ET
    $CNC
    Medical Specialities
    Health Care

    Centene downgraded by Cantor Fitzgerald with a new price target

    Cantor Fitzgerald downgraded Centene from Overweight to Neutral and set a new price target of $38.00

    7/28/25 8:33:52 AM ET
    $CNC
    Medical Specialities
    Health Care

    Centene downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Centene from Overweight to Equal Weight and set a new price target of $30.00

    7/23/25 7:38:36 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    $MGLN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer London Sarah bought $490,365 worth of shares (19,230 units at $25.50), increasing direct ownership by 2% to 845,275 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    8/11/25 5:28:22 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Samuels Theodore R. Ii bought $248,580 worth of shares (9,000 units at $27.62) (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    7/29/25 6:01:58 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Greco Thomas bought $1,015,750 worth of shares (17,000 units at $59.75), increasing direct ownership by 736% to 19,309 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    12/19/24 5:39:30 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    $MGLN
    Leadership Updates

    Live Leadership Updates

    View All

    eHealth Announces CEO Succession

    Derrick Duke Appointed Chief Executive Officer After Transition Period Fran Soistman to Retire, Remain on eHealth Board of Directors AUSTIN, Texas, July 29, 2025 /PRNewswire/ -- eHealth, Inc. (NASDAQ:EHTH), a leading private online health insurance marketplace (the "Company"), today announced that the Company's Board of Directors has appointed Derrick Duke as its next Chief Executive Officer. Duke will join eHealth on August 4th 2025, to begin the transition process before officially stepping into the CEO role and joining the Board of Directors on September 18th, 2025. He will succeed Fran Soistman, who, as previously announced, will retire from his role as CEO while continuing to serve on t

    7/29/25 9:00:00 AM ET
    $CNC
    $EHTH
    Medical Specialities
    Health Care
    Specialty Insurers
    Finance

    NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

    Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO

    5/7/25 2:00:00 PM ET
    $CNC
    $LFST
    Medical Specialities
    Health Care
    Medical/Nursing Services

    CENTENE APPOINTS KENNETH Y. TANJI TO BOARD OF DIRECTORS

    ST. LOUIS, Feb. 24, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today the appointment of Kenneth Y. Tanji to the Centene Board of Directors, effective February 20, 2025. Mr. Tanji will serve on the Company's Audit and Compliance Committee. The appointment of Mr. Tanji expands Centene's Board of Directors to 12 members. Mr. Tanji's finance acumen spans more than three decades and includes deep knowledge of capital optimization strategies, strategic acquisitions, JV partnership models and the use of advanced analytics and technologies to scale g

    2/24/25 4:15:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    $MGLN
    Financials

    Live finance-specific insights

    View All

    CENTENE CORPORATION REPORTS THIRD QUARTER 2025 RESULTS

    -- GAAP Diluted Loss Per Share of $(13.50); Adjusted Diluted Earnings Per Share of $0.50 -- Adjusted diluted EPS of $0.50 in the third quarter of 2025, including a $0.10 benefit of a low adjusted effective tax rate in the quarter as compared to the expected full year adjusted effective tax rate of 20-21%.$6.7 billion non-cash goodwill impairment, resulting in a GAAP loss and corresponding reduction of retained earnings in the third quarter of 2025. After the reduction to retained earnings, the debt-to-capital ratio was 45.5% at September 30, 2025.Medicaid HBR of 93.4% in the third quarter, including an approximate 40 basis point benefit from a retroactive revenue adjustment attributed to the

    10/29/25 6:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    CENTENE CORPORATION TO HOST 2025 THIRD QUARTER FINANCIAL RESULTS EARNINGS CALL CALL SCHEDULED FOR 9AM ET

    ST. LOUIS, Sept. 29, 2025 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 third quarter financial results at approximately 6:00 a.m. ET on Wednesday, October 29, 2025, and host a conference call at 9:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 0266211 to ex

    9/29/25 9:57:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    CENTENE CORPORATION REPORTS SECOND QUARTER 2025 RESULTS

    -- Diluted Loss Per Share of $(0.51); Adjusted Diluted Loss Per Share of $(0.16) -- ST. LOUIS, July 25, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) (the Company) announced today its financial results for the second quarter ended June 30, 2025. In summary, the 2025 second quarter results were as follows: Total revenues (in millions) $             48,742 Premium and service revenues (in millions) $             42,467 Health benefits ratio 93.0 % SG&A expense ratio 7.1 % Adjusted SG&A expense ratio (1) 7.1 % GAAP diluted loss per share $                (0.51) Adjusted diluted loss per share (1) $                (0.16) Total cash flow provided by operations (in millions) $              

    7/25/25 6:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    $MGLN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Centene Corporation

    SC 13G - CENTENE CORP (0001071739) (Subject)

    11/14/24 4:06:01 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Centene Corporation

    SC 13G/A - CENTENE CORP (0001071739) (Subject)

    11/13/24 3:02:23 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Centene Corporation

    SC 13G/A - CENTENE CORP (0001071739) (Subject)

    11/12/24 9:55:15 AM ET
    $CNC
    Medical Specialities
    Health Care